CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from GermanyPeter Bader, Andrea Jarisch, Fabian Müller et al.|Blood Advances|2023Cited by 57
CD34<sup>+</sup> selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantationChiara Mainardi, Peter Lang, Martin Ebinger et al.|British Journal of Haematology|2017Cited by 47
Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host DiseaseMichaela Döring, Ingo Müller, Karin Melanie Cabanillas Stanchi et al.|Stem Cells and Development|2021Cited by 34
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trialAnna Eichinger, Michael H. Albert, Ulrike Pöetschger et al.|Leukemia|2022Cited by 26
Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioningKatharina Wustrau, Kai Lehmberg, Johann Greil et al.|Pediatric Blood & Cancer|2020Cited by 19